Company | Name | Exchange | Sector | Industry | 6 Month | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eurobio Scientific | Paris | Healthcare | Biotechnology & Medical Research | 75.7% | €257.62M | 42.7x | -1.73 | €25.65 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17% Upside | Upgrade to Pro+ | |
Aramis | Paris | Consumer Cyclicals | Diversified Retail | 60% | €651.54M | -16.9x | €7.82 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -6.1% Downside | Upgrade to Pro+ | ||
Explosifs Prod Chimiques | Paris | Basic Materials | Chemicals | 32% | €397.54M | 18.7x | 1.04 | €188.50 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.7% Upside | Upgrade to Pro+ | |
Axway | Paris | Technology | Software & IT Services | 25.2% | €787.16M | 16x | 0.12 | €27.10 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.3% Upside | Upgrade to Pro+ |